SynDiag began as a spin-off from the Polytechnic University of Turin and is now a manufacturer registered at the Italian Ministry of Health. Our research is not merely a technological endeavor, but a methodological commitment aimed at ensuring that Artificial Intelligence serves as an objective, safe, and clinically validated medical support tool.
At the core of our scientific integrity:

Nine years of research and development have resulted in the filing of six international patents (Europe, the U.S., and Asia). This technological continuity ensures a proprietary, robust solution that is recognized by leading global authorities.

The reliability of our algorithms stems from the quality of their training. We have analyzed and validated over 2,000 real-world cases, enabling the AI to learn from a vast dataset certified by medical experts.

We collaborate with 12 leading clinical centers in Italy and abroad. Testing the technology in a variety of settings—from IRCCS to university hospitals—ensures that the system is robust and reliable regardless of the clinical setting.
Patient safety is ensured through compliance with the most stringent international standards.
We are at the forefront of integrating the requirements of the EU Artificial Intelligence Act, operating in full compliance with the Medical Device Regulation (MDR) and the ISO 13485:2016 and ISO 9001:2015 certifications.





We combine technology and clinical practice to support more effective medical decisions and ensure a future of well-being for women around the world



















Whether you are a healthcare professional, an organization, or a woman who chooses prevention, SynDiag is by your side to guide responsible innovation in gynecological health.